An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigen
Limonta-Fernández, Miladys, Chinea-Santiago, Glay, Martín-Dunn, Alejandro Miguel, Gonzalez-Roche, Diamile, Bequet-Romero, Monica, Marquez-Perera, Gabriel, González-Moya, Isabel, Canaan-Haden-Ayala, Camila, Cabrales-Rico, Ania, Espinosa-Rodríguez, Luis Ariel, Ramos-Gómez, Yassel, Andujar-Martínez, Ivan, González-López, Luis Javier, de la Iglesia, Mariela Perez, Zamora-Sanchez, Jesus, Cruz-Sui, Otto, Lemos-Pérez, Gilda, Cabrera-Herrera, Gleysin, Valdes-Hernández, Jorge, Martinez-Diaz, Eduardo, Pimentel-Vazquez, Eulogio, Ayala-Avila, Marta, Guillén-Nieto, Gerardo
Published in New biotechnology (25.12.2022)
Published in New biotechnology (25.12.2022)
Get full text
Journal Article